A PROSPECTIVE STUDY OF THE EFFICACY AND ADVERSE EFFECTS OF TOLVAPTAN FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

被引:0
|
作者
Kai, Hirayasu [2 ]
Tsunoda, Ryoya [2 ]
Kawamura, Tetsuya [2 ]
Fujita, Akiko [2 ]
Kaneko, Shuzo [2 ]
Morito, Naoki [2 ]
Usui, Joichi [2 ]
Saito, Chie [2 ]
Nakamura, Taichi [1 ]
Yamagata, Kunihiro [2 ]
机构
[1] Mito Kyodo Gen Hosp, Nephrol, Mito, Ibaraki, Japan
[2] Univ Tsukuba, Nephrol, Tsukuba, Ibaraki, Japan
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
FP061
引用
收藏
页码:68 / 68
页数:1
相关论文
共 50 条
  • [31] HYPERURICEMIA IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD)
    TANGEL, DJ
    KAEHNY, WD
    DULEY, IT
    JOHNSON, AM
    GABOW, PA
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 211 - 211
  • [32] Preventive project of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Esteban de la Rosa, Rafael J.
    Poyatos Andujar, Antonio Miguel
    Morales Garcia, Ana Isabel
    Martinez Navarro, Luis
    Garcia Valverde, Maria
    Bravo Soto, Juan Antonio
    NEFROLOGIA, 2021, 41 (06): : 704 - 706
  • [33] Interstitial inflammation in autosomal dominant polycystic kidney disease (ADPKD).
    Tao, YX
    Kim, J
    Schrier, RW
    Edelstein, CL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 874A - 874A
  • [34] COMPUTED TOMOGRAPHY IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Patil, Devendra
    Chitnis, Ashutosh
    Khaire, Hrishikesh
    Hira, Rajiv
    Yadav, Pankaj
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (101): : 16707 - 16708
  • [35] Fibrosis and progression of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Norman, Jill
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (10): : 1327 - 1336
  • [36] A POST HOC ANALYSIS OF STATIN USE IN TOLVAPTAN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PIVOTAL TRIALS
    Shoaf, Susan E.
    Ouyang, John
    Sergeyeva, Olga
    Estilo, Alvin
    Li, Hui
    Leung, Deborah
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 734 - 735
  • [37] The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
    Tarabzuni, Ola
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [38] IDENTIFYING THE MAIN PREDICTORS OF URINE OUTPUT IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS TAKING TOLVAPTAN
    Borrego-Utiel, Francisco-Jose
    Morales Garcia, Ana Isabel
    Polo Moyano, Aurora
    Roca Oporto, Francisco
    Merino Garcia, Enoc
    Esteban de la Rosa, Rafael Jose
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I4 - I4
  • [39] Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD
    Dana Rizk
    Arlene Chapman
    Pediatric Nephrology, 2008, 23 : 1029 - 1036
  • [40] Kidney volume enlargement in unilateral autosomal dominant polycystic kidney disease (ADPKD)
    Poster, D.
    Krauer, F.
    Kistler, A.
    Weishaupt, D.
    Wuethrich, R. P.
    Serra, A.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 11S - 11S